Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
FDA Approval Summary: Oral Azacitidine for Continued Treatment of Adults with Acute Myeloid Leukemia Unable to Complete Intensive Curative Therapy.
Clin Cancer Res. 2022 Jul 15;28(14):2989-2993. doi: 10.1158/1078-0432.CCR-21-4525.
Clin Cancer Res. 2022.
PMID: 35325108
Free PMC article.
Clinical Trial.
FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid Leukemia.
Jen EY, Ko CW, Lee JE, Del Valle PL, Aydanian A, Jewell C, Norsworthy KJ, Przepiorka D, Nie L, Liu J, Sheth CM, Shapiro M, Farrell AT, Pazdur R.
Jen EY, et al.
Clin Cancer Res. 2018 Jul 15;24(14):3242-3246. doi: 10.1158/1078-0432.CCR-17-3179. Epub 2018 Feb 23.
Clin Cancer Res. 2018.
PMID: 29476018
Item in Clipboard
FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease.
Jen EY, Xu Q, Schetter A, Przepiorka D, Shen YL, Roscoe D, Sridhara R, Deisseroth A, Philip R, Farrell AT, Pazdur R.
Jen EY, et al.
Clin Cancer Res. 2019 Jan 15;25(2):473-477. doi: 10.1158/1078-0432.CCR-18-2337. Epub 2018 Sep 25.
Clin Cancer Res. 2019.
PMID: 30254079
Item in Clipboard
FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm.
Jen EY, Gao X, Li L, Zhuang L, Simpson NE, Aryal B, Wang R, Przepiorka D, Shen YL, Leong R, Liu C, Sheth CM, Bowen S, Goldberg KB, Farrell AT, Blumenthal GM, Pazdur R.
Jen EY, et al.
Clin Cancer Res. 2020 Feb 1;26(3):532-536. doi: 10.1158/1078-0432.CCR-19-2329. Epub 2019 Sep 23.
Clin Cancer Res. 2020.
PMID: 31548341
Item in Clipboard
Considerations for Drug Development in Myelodysplastic Syndromes.
Sekeres MA, Kim N, DeZern AE, Norsworthy KJ, Garcia JS, de Claro RA, Theoret MR, Jen EY, Ehrlich LA, Zeidan AM, Komrokji RS.
Sekeres MA, et al. Among authors: jen ey.
Clin Cancer Res. 2023 Jul 14;29(14):2573-2579. doi: 10.1158/1078-0432.CCR-22-3348.
Clin Cancer Res. 2023.
PMID: 36688922
Free PMC article.
Item in Clipboard
Minimal Residual Disease Data in Hematologic Malignancy Drug Applications and Labeling: An FDA Perspective.
Baines AC, Yazdy MS, Kasamon YL, Ershler R, Jen EY, Kanapuru B, Richardson NC, Lane A, Carioti T, Theoret MR, Pazdur R, Gormley NJ.
Baines AC, et al. Among authors: jen ey.
Clin Cancer Res. 2023 Aug 1;29(15):2748-2752. doi: 10.1158/1078-0432.CCR-22-3579.
Clin Cancer Res. 2023.
PMID: 36892497
Free PMC article.
Item in Clipboard
IL-2 regulates the expression of the tumor suppressor IL-24 in melanoma cells.
Jen EY, Poindexter NJ, Farnsworth ES, Grimm EA.
Jen EY, et al.
Melanoma Res. 2012 Feb;22(1):19-29. doi: 10.1097/CMR.0b013e32834d2506.
Melanoma Res. 2012.
PMID: 22027907
Free PMC article.
Item in Clipboard
Sonic hedgehog induces epidermal growth factor dependent matrix infiltration in HaCaT keratinocytes.
Bigelow RL, Jen EY, Delehedde M, Chari NS, McDonnell TJ.
Bigelow RL, et al. Among authors: jen ey.
J Invest Dermatol. 2005 Feb;124(2):457-65. doi: 10.1111/j.0022-202X.2004.23590.x.
J Invest Dermatol. 2005.
PMID: 15675968
Free article.
Item in Clipboard
Cite
Cite